Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Kidney Neoplasms × CTLA-4 Antigen × Clear all

Sponsor

Conditions

Melanoma 11 Uveal Melanoma 3 Sarcoma 2 Neoplasm Metastasis 2 Lymphoma, Non-Hodgkin 2 Leukemia, Biphenotypic, Acute 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Sarcoma, Kaposi 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Recurrent Squamous Cell Lung Carcinoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1

Interventions

Sunitinib 16 Everolimus 15 Bevacizumab 12 aldesleukin 10 Sorafenib 10 Cyclophosphamide 10 Nivolumab 9 Interleukin-2 9 fludarabine phosphate 7 fludarabine 7 Axitinib 7 Gemcitabine 5 temsirolimus 4 pembrolizumab 4 pazopanib 4 Ipilimumab 4 peginterferon alfa-2b 3 durvalumab 3 Radiosurgery 3 Interferon-alpha 3 Filgrastim 3 Erlotinib Hydrochloride 3 Cryosurgery 3 vandetanib 2 perflutren 2 ixabepilone 2 chiron 2 carfilzomib 2 cabozantinib 2 belzutifan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡